1,014
Participants
Start Date
January 31, 2015
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Insulin Glargine (HOE901 - U300)
Self-administered by subcutaneous (SC) injection in the evening using a pre-filled pen. Dose titration to achieve fasting self-monitored plasma glucose (SMPG) from 90 to 130 mg/dL (5.0 to 7.2 mmol/L).
Insulin Glargine (HOE901 - U100)
Self-administered by SC injection in the evening using a pre-filled pen. Dose titration to achieve fasting SMPG from 90 to 130 mg/dL (5.0 to 7.2 mmol/L).
Background therapy
Non-insulin anti-diabetic drugs with the exception of thiazolidinediones.
Investigational Site Number 604002, Lima
Investigational Site Number 348001, Budapest
Investigational Site Number 348005, Budapest
Investigational Site Number 348007, Budapest
Investigational Site Number 032001, Caba
Investigational Site Number 032006, Capital Federal
Investigational Site Number 032004, Ciudad Autonoma de Buenos Aire
Investigational Site Number 348003, Budapest
Investigational Site Number 032002, Caba
Investigational Site Number 036004, Fitzroy
Investigational Site Number 036002, Box Hill
Investigational Site Number 036001, Geelong
Investigational Site Number 036003, Herston
Investigational Site Number 348009, Debrecen
Investigational Site Number 348002, Gyula
Investigational Site Number 348008, Csongrád
Investigational Site Number 032003, Mar del Plata
Investigational Site Number 348004, Balatonfüred
Investigational Site Number 840018, New York
Investigational Site Number 724003, Sanlúcar de Barrameda
Investigational Site Number 276005, Potsdam
Investigational Site Number 724008, A Coruña
Investigational Site Number 840017, Pittsburgh
Investigational Site Number 724002, Ferrol
Investigational Site Number 380003, Genova
Investigational Site Number 840045, Feasterville
Investigational Site Number 604003, Piura
Investigational Site Number 380002, Milan
Investigational Site Number 380001, Milan
Investigational Site Number 484002, Aguascalientes
Investigational Site Number 840060, Bridgeport
Investigational Site Number 840011, Greensboro
Investigational Site Number 840047, Greenville
Investigational Site Number 840016, Salisbury
Investigational Site Number 840009, Charlotte
Investigational Site Number 840012, Wilmington
Investigational Site Number 840048, Asheville
Investigational Site Number 724006, Málaga
Investigational Site Number 840059, Greenville
Investigational Site Number 840015, Greer
Investigational Site Number 840041, Roswell
Investigational Site Number 840042, Woodstock
Investigational Site Number 840053, Statesboro
Investigational Site Number 840010, Miami
Investigational Site Number 840035, Miami
Investigational Site Number 840030, Bradenton
Investigational Site Number 840014, New Port Richey
Investigational Site Number 840056, Palm Harbor
Investigational Site Number 840051, Ocoee
Investigational Site Number 840058, Saraland
Investigational Site Number 840002, Chattanooga
Investigational Site Number 840046, Chattanooga
Investigational Site Number 840034, Knoxville
Investigational Site Number 380004, Bologna
Investigational Site Number 724005, Seville
Investigational Site Number 250006, Nantes
Investigational Site Number 484001, Guadalajara
Investigational Site Number 840054, Wadsworth
Investigational Site Number 840072, Cincinnati
Investigational Site Number 276003, Essen
Investigational Site Number 840013, Avon
Investigational Site Number 840023, Avon
Investigational Site Number 724004, Alzira
Investigational Site Number 724007, Quart de Poblet
Investigational Site Number 840006, Muncie
Investigational Site Number 840039, Evansville
Investigational Site Number 840020, Flint
Investigational Site Number 840033, West Des Moines
Investigational Site Number 840026, Des Moines
Investigational Site Number 840022, Fargo
Investigational Site Number 840005, Arlington Heights
Investigational Site Number 840004, Peoria
Investigational Site Number 484004, Cuernavaca
Investigational Site Number 840029, Springfield
Investigational Site Number 484003, Monterrey
Investigational Site Number 380005, Chieti
Investigational Site Number 840032, Overland Park
Investigational Site Number 276002, Saarlouis
Investigational Site Number 250004, Lyon
Investigational Site Number 840069, Metairie
Investigational Site Number 840024, Irving
Investigational Site Number 840001, Dallas
Investigational Site Number 840055, Arlington
Investigational Site Number 840061, North Richland Hills
Investigational Site Number 840028, Richmond
Investigational Site Number 840063, San Antonio
Investigational Site Number 752003, Rättvik
Investigational Site Number 170007, Barranquilla
Investigational Site Number 840027, Longmont
Investigational Site Number 276001, München
Investigational Site Number 840038, St. George
Investigational Site Number 250005, Poitiers
Investigational Site Number 840064, Los Angeles
Investigational Site Number 840070, Huntington Park
Investigational Site Number 840031, Norwalk
Investigational Site Number 840003, Temecula
Investigational Site Number 840050, Orange
Investigational Site Number 840036, Simi Valley
Investigational Site Number 840019, Fresno
Investigational Site Number 840021, Fresno
Investigational Site Number 840062, Walnut Creek
Investigational Site Number 840065, Oakland
Investigational Site Number 840040, Greenbrae
Investigational Site Number 840057, Corvallis
Investigational Site Number 840067, Bend
Investigational Site Number 840025, Federal Way
Investigational Site Number 170001, Bogotá
Investigational Site Number 170005, Bogotá
Investigational Site Number 170003, Manizales
Investigational Site Number 642004, Oradea
Investigational Site Number 642002, Târgu Mureş
Investigational Site Number 642003, Târgu Mureş
Investigational Site Number 642005, Sibiu
Investigational Site Number 642006, Bacau
Investigational Site Number 170004, Armenia
Investigational Site Number 642007, Constanța
Investigational Site Number 840007, St. Petersburg
Investigational Site Number 392008, Adachi-Ku
Investigational Site Number 392003, Atsugi-Shi
Investigational Site Number 392002, Kamakura-Shi
Investigational Site Number 392010, Sagamihara-Shi
Investigational Site Number 392004, Sakado-Shi
Investigational Site Number 392013, Sapporo
Investigational Site Number 392012, Sendai
Investigational Site Number 604004, Arequipa
Investigational Site Number 840037, Nashua
Investigational Site Number 124003, Brampton
Investigational Site Number 124005, Burlington
Investigational Site Number 124008, Chatham
Investigational Site Number 124010, Mirabel
Investigational Site Number 124009, Montreal
Investigational Site Number 124006, Sainte-Foy
Investigational Site Number 124004, Thornhill
Investigational Site Number 124002, Toronto
Investigational Site Number 124001, Vancouver
Investigational Site Number 124007, Vancouver
Investigational Site Number 276004, Dresden
Investigational Site Number 604007, Ica
Investigational Site Number 604005, Lima
Investigational Site Number 604001, Lima
Investigational Site Number 604006, Lima
Investigational Site Number 616005, Lublin
Investigational Site Number 616004, Szczecin
Investigational Site Number 616003, Warsaw
Investigational Site Number 616002, Warsaw
Investigational Site Number 616001, Zabrze
Investigational Site Number 642001, Bucharest
Investigational Site Number 410003, Seoul
Investigational Site Number 410005, Seoul
Investigational Site Number 410002, Seoul
Investigational Site Number 410001, Seoul
Investigational Site Number 410004, Wŏnju
Investigational Site Number 724001, Badalona
Investigational Site Number 752002, Gothenburg
Investigational Site Number 752004, Härnösand
Investigational Site Number 752001, Västra Frölunda
Investigational Site Number 826003, Belfast
Investigational Site Number 826005, Belfast
Investigational Site Number 826001, Bristol
Investigational Site Number 826004, Redhill
Investigational Site Number 826006, Rotherham
Investigational Site Number 826002, Swansea
Lead Sponsor
Sanofi
INDUSTRY